ГЛОФТРИНІД
Analogs of ГЛОФТРИНІД
Find cheaper analogs and generic equivalents for ГЛОФТРИНІД.
Active Ingredient: Bortezomib
Product Overview
About ГЛОФТРИНІД
ГЛОФТРИНІД is a medication that contains the active ingredient Bortezomib, a proteasome inhibitor used in the treatment of certain types of cancer. It is specifically designed to target and inhibit the 26S proteasome, a protein complex involved in degrading ubiquitinated proteins. This mechanism of action disrupts various cellular processes, leading to cell cycle arrest and apoptosis, particularly in cancer cells.
Key Benefits & Uses
- Treatment of multiple myeloma, a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow
- Treatment of mantle cell lymphoma, a subtype of non-Hodgkin's lymphoma
- Palliative care to relieve symptoms and improve quality of life in patients with certain types of cancer
Active Ingredient & Action
Bortezomib, the active ingredient in ГЛОФТРИНІД, works by covalently binding to the catalytic sites of the 26S proteasome, inhibiting its activity. This inhibition leads to an accumulation of defective proteins in the cell, triggering a stress response and ultimately leading to cell death. The selective toxicity of Bortezomib towards cancer cells makes it an effective treatment option for various hematological malignancies.
Important Notes
Patients taking ГЛОФТРИНІД should be closely monitored for potential side effects, including peripheral neuropathy, thrombocytopenia, and neutropenia. It is essential to follow the prescribed dosage and administration schedule to minimize the risk of adverse effects. Additionally, patients should discuss their medical history, including any pre-existing conditions or concomitant medications, with their healthcare provider before starting treatment with ГЛОФТРИНІД.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.